| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e3830f35387a1c32061dea3ee310851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_588f4799eeda38576f3d4784cef85ded
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ac31571d6b45b03414c3aac8d209cf5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26717adda9d025fcb5531da41a17f44b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7952e0eae5bdb40b481d6db402c04792
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_390be8b40737dd62f57f366e17a9af5d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-505 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 |
| filingDate |
2011-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8105d1d0fb14e37591e047ce85728897
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f107963e9ab96ef086bc5c084a61a85a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e40e13220718d9c6df686fff07922b8 |
| publicationDate |
2012-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012075291-A1 |
| titleOfInvention |
Compositions and methods for treating foxp3+ treg related diseases |
| abstract |
Methods for treating or preventing a Foxp3+ T regulatory cell (Treg) related disease in a subject in need thereof comprise administering to the subject an effective amount of a pharmaceutical composition comprising an inhibitor of a histone/protein acetyltransferase (HAT). Methods for identifying an agent useful for treating or preventing a Foxp3+ T regulatory cell (Treg) related disease comprise (a) contacting a candidate agent with a test sample comprising Foxp3+ T regulatory cells (Tregs), and (b) comparing a function of the Foxp3+ Tregs in the test sample with that in a control sample, wherein inhibition of the function of the Foxp3+ Tregs in the test sample when compared with the control sample indicates that the candidate agent is an agent useful for treating or preventing a Foxp3+ Treg related disease. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10981989-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023057931-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11643464-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10519237-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160133510-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10010504-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11492405-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11732046-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10995141-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102248804-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016045437-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10618963-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10961309-B2 |
| priorityDate |
2010-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |